Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie L Hutton

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Helicobacter|February 12, 2015
Increased Outer Membrane Vesicle Formation in a Helicobacter pylori tolB MutantLorinda Turner, Judyta Praszkier, Melanie L Hutton, et al.
The Journal of Infectious Diseases|February 23, 2018
Intestinal Colonization Traits of Pandemic Multidrug-Resistant Escherichia coli ST131Sohinee Sarkar, Melanie L Hutton, Dimitrios Vagenas, et al.
Genes|December 26, 2015
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic ResistancePriscilla A Johanesen, Kate E Mackin, Melanie L Hutton, et al.
Human Vaccines & Immunotherapeutics|November 12, 2016
Options for improving effectiveness of rotavirus vaccines in developing countriesMarion S Tissera, Daniel Cowley, Nada Bogdanovic-Sakran, et al.
Scientific Reports|June 18, 2017
Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternativeMelanie L Hutton, Bliss A Cunningham, Kate E Mackin, et al.
Cellular Microbiology|October 31, 2012
A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion systemRebecca J Gorrell, Jyeswei Guan, Yue Xin, et al.
Nature Microbiology|August 14, 2019
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infectionYogitha N Srikhanta, Melanie L Hutton, Milena M Awad, et al.
Gut Microbes|September 1, 2022
Bezlotoxumab prevents extraintestinal organ damage induced by <i>Clostridioides difficile</i> infectionSteven J Mileto, Melanie L Hutton, Sarah L Walton, et al.
Frontiers in Cellular and Infection Microbiology|June 22, 2017
A <i>Helicobacter pylori</i> Homolog of Eukaryotic Flotillin Is Involved in Cholesterol Accumulation, Epithelial Cell Responses and Host ColonizationMelanie L Hutton, Kimberley D'Costa, Amanda E Rossiter, et al.
Anaerobe|December 1, 2018
A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strainMichael C Wehrhahn, Caitlin Keighley, Jelica Kurtovic, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Helicobacter|February 12, 2015
Increased Outer Membrane Vesicle Formation in a Helicobacter pylori tolB MutantLorinda Turner, Judyta Praszkier, Melanie L Hutton, et al.
The Journal of Infectious Diseases|February 23, 2018
Intestinal Colonization Traits of Pandemic Multidrug-Resistant Escherichia coli ST131Sohinee Sarkar, Melanie L Hutton, Dimitrios Vagenas, et al.
Genes|December 26, 2015
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic ResistancePriscilla A Johanesen, Kate E Mackin, Melanie L Hutton, et al.
Human Vaccines & Immunotherapeutics|November 12, 2016
Options for improving effectiveness of rotavirus vaccines in developing countriesMarion S Tissera, Daniel Cowley, Nada Bogdanovic-Sakran, et al.
Scientific Reports|June 18, 2017
Bovine antibodies targeting primary and recurrent Clostridium difficile disease are a potent antibiotic alternativeMelanie L Hutton, Bliss A Cunningham, Kate E Mackin, et al.
Cellular Microbiology|October 31, 2012
A novel NOD1- and CagA-independent pathway of interleukin-8 induction mediated by the Helicobacter pylori type IV secretion systemRebecca J Gorrell, Jyeswei Guan, Yue Xin, et al.
Nature Microbiology|August 14, 2019
Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infectionYogitha N Srikhanta, Melanie L Hutton, Milena M Awad, et al.
Gut Microbes|September 1, 2022
Bezlotoxumab prevents extraintestinal organ damage induced by <i>Clostridioides difficile</i> infectionSteven J Mileto, Melanie L Hutton, Sarah L Walton, et al.
Frontiers in Cellular and Infection Microbiology|June 22, 2017
A <i>Helicobacter pylori</i> Homolog of Eukaryotic Flotillin Is Involved in Cholesterol Accumulation, Epithelial Cell Responses and Host ColonizationMelanie L Hutton, Kimberley D'Costa, Amanda E Rossiter, et al.
Anaerobe|December 1, 2018
A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strainMichael C Wehrhahn, Caitlin Keighley, Jelica Kurtovic, et al.
Pageof 3